Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Merve Ertaş, Sevde Nur Biltekin, Barkın Berk, Leyla Yurttaş & Şeref Demirayak. (2022) Synthesis of some 5,6-diaryl-1,2,4-triazine derivatives and investigation of their cyclooxygenase (COX) inhibitory activity. Phosphorus, Sulfur, and Silicon and the Related Elements 197:11, pages 1123-1135.
Read now
Read now
Jay L Goldstein & Byron Cryer. (2015) Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug, Healthcare and Patient Safety 7, pages 31-41.
Read now
Read now
B. Jönsson, U. Haglund. (2001) Economic Burden of NSAID-induced Gastropathy in Sweden. Scandinavian Journal of Gastroenterology 36:7, pages 775-779.
Read now
Read now
Articles from other publishers (32)
Serap KORKMAZ & Zafer TABUR. (2023) İndometazin İle İndüklenerek Oluşturulan Gastrik Ülsere Karşı Propolisin Etkinliğinin BelirlenmesiDetermination of the Efficacy of Propolis Against Indomethacin-Induced Gastric Ulcer. Erciyes Tarım ve Hayvan Bilimleri Dergisi 6:2, pages 67-73.
Crossref
Crossref
B.Y. Cooper, T.J. Nutter, L.D. Flunker & C.M. Bowers. (2022) Combinations of classical and non-classical voltage dependent potassium channel openers suppress nociceptor discharge and reverse chronic pain signs in a rat model of Gulf War illness. NeuroToxicology 93, pages 186-199.
Crossref
Crossref
Prince Allawadhi, Amit Khurana, Nilofer Sayed, Chandraiah Godugu & Divya Vohora. (2022) Ameliorative effect of cerium oxide nanoparticles against Freund’s complete adjuvant-induced arthritis. Nanomedicine 17:6, pages 383-404.
Crossref
Crossref
Edmundas Kaduševičius. (2021) Novel Applications of NSAIDs: Insight and Future Perspectives in Cardiovascular, Neurodegenerative, Diabetes and Cancer Disease Therapy. International Journal of Molecular Sciences 22:12, pages 6637.
Crossref
Crossref
L. McEvoy, D. F. Carr & M. Pirmohamed. (2021) Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Frontiers in Pharmacology 12.
Crossref
Crossref
Mircea Hîrjău, Dalia Simona Miron, Valentina Anuța, Dumitru Lupuliasa, Mihaela Violeta Ghica, Viorel Jinga & Cristina-Elena Dinu-Pîrvu. (2020) Evaluation of Experimental Multi-Particulate Polymer-Coated Drug Delivery Systems with Meloxicam. Coatings 10:5, pages 490.
Crossref
Crossref
Prashant R. Murumkar & Rupesh V. Chikhale. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles
191
219
.
M. Muñoz-Navas, M. Betés & S. de la Riva. (2016) Manifestaciones gastrointestinales de las enfermedades sistémicas y cutáneas. Medicine - Programa de Formación Médica Continuada Acreditado 12:3, pages 128-136.
Crossref
Crossref
N G Burnet, P Nasr, G Yip, J E Scaife, T House, S J Thomas, F Harris, P J Owen & P Hull. (2014) Prophylactic radiotherapy against heterotopic ossification following internal fixation of acetabular fractures: a comparative estimate of risk. The British Journal of Radiology 87:1042, pages 20140398.
Crossref
Crossref
Manish Kumar, Subodh Kumar & Satwinderjeet Kaur. (2012) Role of ROS and COX-2/iNOS inhibition in cancer chemoprevention: a review. Phytochemistry Reviews 11:2-3, pages 309-337.
Crossref
Crossref
K. D. RainsfordK. D. Rainsford. 2012. Ibuprofen: Pharmacology, Therapeutics and Side Effects. Ibuprofen: Pharmacology, Therapeutics and Side Effects
91
122
.
Beyzagul Polat, Halis Suleyman & Hamit Hakan Alp. (2010) Adaptation of rat gastric tissue against indomethacin toxicity. Chemico-Biological Interactions 186:1, pages 82-89.
Crossref
Crossref
Deborah P. Lubeck. 2007. Clinical Research Methods for Surgeons. Clinical Research Methods for Surgeons
95
104
.
Jay S Cohen. (2005) How Celecoxib Could Be Safer, How Valdecoxib Might Have Been. Annals of Pharmacotherapy 39:9, pages 1542-1545.
Crossref
Crossref
Bryan F Mitchell & David M Olson. (2004) Prostaglandin endoperoxide H synthase inhibitors and other tocolytics in preterm labour. Prostaglandins, Leukotrienes and Essential Fatty Acids 70:2, pages 167-187.
Crossref
Crossref
Regina M. Botting & Jack H. Botting. 2004. COX-2 Inhibitors. COX-2 Inhibitors
1
13
.
Jeanne M. Wallace. (2016) Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy. Integrative Cancer Therapies 1:1, pages 7-37.
Crossref
Crossref
Natasha May, Joel Epstein & Barrie Osborne. (2001) Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 92:4, pages 399-405.
Crossref
Crossref
Richard A. Jones. (2001) Etodolac (Lodine®): Profile of an established selective COX-2 inhibitor. InflammoPharmacology 9:1-2, pages 63-70.
Crossref
Crossref
PAUL A. MOORE & ELLIOT V. HERSH. (2001) Celecoxib and rofecoxib. The Journal of the American Dental Association 132:4, pages 451-456.
Crossref
Crossref
Gary W. Williams, Richard C. Hubbard, Shawn S. Yu, William Zhao & G. Steven Geis. (2001) Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee. Clinical Therapeutics 23:2, pages 213-227.
Crossref
Crossref
Gerson T. Lesser. (2000) The clinical role of COX-2 inhibitors. Gastroenterology 118:3, pages 639-640.
Crossref
Crossref
John R Vane & Regina M Botting. (2000) The future of NSAID therapy: selective COX‐2 inhibitors. International Journal of Clinical Practice 54:1, pages 7-9.
Crossref
Crossref
J. R. Vane. 2000. Advances in Eicosanoid Research. Advances in Eicosanoid Research
1
23
.
. (1999) Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs. New England Journal of Medicine 341:18, pages 1397-1399.
Crossref
Crossref
David Bjorkman. (1998) Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. The American Journal of Medicine 105:5, pages 17S-21S.
Crossref
Crossref
X. Wang. (1998) A chelate theory for the mechanism of action of aspirin-like drugs. Medical Hypotheses 50:3, pages 239-251.
Crossref
Crossref
X. Wang. (1998) Aspirin-like drugs cause gastrointestinal injuries by metallic cation chelation. Medical Hypotheses 50:3, pages 227-238.
Crossref
Crossref
D. Henry, A. Drew & S. Beuzeville. 1998. Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs. Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs
19
45
.
J. R. Vane & R. M. Botting. 1998. Selective COX-2 Inhibitors. Selective COX-2 Inhibitors
1
17
.
Jay L. Goldstein, Leanne R. Larson, Beverly D. Yamashita & Mark S. Boyd. (1997) Management of NSAID-induced gastropathy: an economic decision analysis. Clinical Therapeutics 19:6, pages 1496-1509.
Crossref
Crossref
Gary R Matzke. (2017) Clinical Consequences of Nonnarcotic Analgesic Use. Annals of Pharmacotherapy 31:2, pages 245-248.
Crossref
Crossref